RJA
EMN icon

Raymond James & Associates’s Eastman Chemical EMN Stock Holding History

Raymond James & Associates’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,700
Closed -$24K – 3323
2016
Q4 		$24K Buy
+12,700
New +$917K ﹤0.01% 3136

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James & Associates's EMN Position: Q3 2024 in Review

Raymond James & Associates increased its Eastman Chemical (EMN) stake by 6.8% in Q3 2024, buying an estimated $3.64M and bringing the position to 572,808 shares worth $64.1M. The position accounts for 0.04% of the portfolio, ranked #377.

Raymond James & Associates first reported a position in EMN in Q2 2013 and has held it in 46 quarters since. 783 funds tracked by Wall St. Rank hold EMN as of Q3 2024.

  • Raymond James & Associates held 572,808 shares of Eastman Chemical worth $64.1M as of Q3 2024.
  • Raymond James & Associates bought 36,365 Eastman Chemical shares in Q3 2024, an estimated $3.64M.
  • Eastman Chemical made up 0.04% of Raymond James & Associates's portfolio in Q3 2024, its #377 holding.
  • Raymond James & Associates first reported a position in Eastman Chemical in Q2 2013 and has held it in 46 quarters since.
  • 783 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.